Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and appointments, here’s a quick look at which stocks will be in focus in today's trade:
Adani Power, Indus Towers, Indian Oil Corporation, Ajanta Pharma, Bandhan Bank, Coromandel International, CRISIL, Equitas Small Finance Bank, Exide Industries, Federal Bank, Godrej Agrovet, Greaves Cotton, Orient Green Power Company, Jindal Steel & Power, JSW Infrastructure, KSB, Paras Defence and Space Technologies, Phoenix Mills, Skipper, Sona BLW Precision Forgings, Sundram Fasteners, Ujjivan Small Finance Bank, Varun Beverages, and Vedanta will release quarterly earnings on April 30.
Adani Enterprises, Adani Ports and Special Economic Zone, Eternal (Zomato), 5paisa Capital, Bondada Engineering, Home First Finance Company India, Jaiprakash Power Ventures Nuvoco Vistas Corporation, RailTel Corporation of India, and SIS will announce their March 2025 quarter earnings on May 1.
Bajaj Finance Q4 (Consolidated YoY)
Profit grows 19% to Rs 4,546 crore Vs Rs 3,825 crore
Net interest income soars 22% to Rs 9,807 crore Vs Rs 8,013 crore
Assets under management (AUM) grows 26% to Rs 4,16,661 crore Vs Rs 3,30,615 crore as of 31March2024. AUM grew by z 18,618 crore in 04 FY25.
Board announces bonus equity shares in 4:1 ratio, stock split in 2:1 ratio
Board recommends final dividend of Rs 44 per share, special dividend of Rs 12 per share
Bajaj Finserv Q4 (Consolidated YoY)
Profit jumps 14.1% to Rs 2,416.6 crore Vs Rs 2,118.5 crore
Revenue increases 14.2% to Rs 36,595.4 crore Vs Rs 32,040.8 crore
Bharat Petroleum Corporation (BPCL) Q4 (Standalone QoQ)
Profit sinks 30.9% to Rs 3,214.1 crore Vs Rs 4,649.2 crore
Revenue declines 1.7% to Rs 1,11,179 crore Vs Rs 1,13,136 crore
Board recommends final dividend of Rs 5 per share
Jana Small Finance Bank Q4 (YoY)
Profit tanks 61.6% to Rs 123.5 crore Vs Rs 321.7 crore
Net interest income rises 0.9% to Rs 596.9 crore Vs Rs 591.8 crore
Tax credit at Rs 3.64 crore Vs tax credit at Rs 155.2 crore
Gross NPA falls to 2.71% Vs 2.80% (QoQ)
Net NPA flat at 0.94% (QoQ)
UTI Asset Management Company Q4 (Standalone YoY)
Profit drops 18% to Rs 124 crore Vs Rs 151.3 crore
Revenue declines 3.2% to Rs 316.9 crore Vs Rs 327.5 crore
Board recommends final dividend of Rs 26 per share, special dividend of Rs 22 per share
Star Health and Allied Insurance Company Q4 (YoY)
Profit plunges 99.6% to Rs 0.51 crore Vs Rs 142.3 crore
Net premium earned grows 11.9% to Rs 3,798.3 crore Vs Rs 3,395.3 crore
Underwriting loss widens to Rs 275.2 crore Vs loss of Rs 91.8 crore
Operating loss stands at Rs 86.9 crore Vs operating profit of Rs 90 core
Ceat Q4 (Consolidated YoY)
Profit falls 8.4% to Rs 99.5 crore Vs Rs 108.6 crore
Revenue increases 14.3% to Rs 3,420.6 crore Vs Rs 2,991.9 crore
Board recommends dividend of Rs 30 per share
Vishal Mega Mart Q4 (Consolidated YoY)
Profit zooms 88% to Rs 115.1 crore Vs Rs 61.2 crore
Revenue grows 23.2% to Rs 2,547.9 crore Vs Rs 2,068.9 crore
Shoppers Stop Q4 (Consolidated YoY)
Profit sinks 91.4% to Rs 1.99 crore Vs Rs 23.2 crore
Revenue grows 1.7% to Rs 1,064 crore Vs Rs 1,046.3 crore
Board appoints Nirvik Singh, Non-Executive Director, as Chairman of the company
BS Nagesh retires as Chairman and Non- Executive Director
CIE Automotive India Q4 (Consolidated YoY)
Profit drops 10.4% to Rs 206.4 crore Vs Rs 230.5 crore
Revenue falls 6.4% to Rs 2,272.6 crore Vs Rs 2,426.8 crore
Praj Industries Q4 (Consolidated YoY)
Profit sinks 56.7% to Rs 39.8 crore Vs Rs 91.9 crore
Revenue drops 15.6% to Rs 859.7 crore Vs Rs 1,018.6 crore
Schaeffler India Q1 (Consolidated YoY)
Profit grows 14.5% to Rs 251.6 crore Vs Rs 219.7 crore
Revenue jumps 16.1% to Rs 2,174.4 crore Vs Rs 1,873.1 crore
Indostar Capital Finance Q4 ((Standalone YoY)
Profit declines 36.5% to Rs 12.4 crore Vs Rs 19.6 crore
Net interest income drops 21.7% to Rs 179.2 crore Vs Rs 228.7 crore
Fedbank Financial Services Q4 (YoY)
Profit increases 5.9% to Rs 71.7 crore Vs Rs 67.7 crore
Net interest income soars 34.6% to Rs 283.3 crore Vs Rs 210.5 crore
IndiaMART InterMESH Q4 (Consolidated YoY)
Profit spikes 81.3% to Rs 180.6 crore Vs Rs 99.6 crore
Revenue grows 12.8% to Rs 355.1 crore Vs Rs 314.7 crore
Board recommends final dividend of Rs 30 per share, special dividend of Rs 20 per share
Stocks to Watch
The digital services and consulting company announced the launch of Infosys Topaz for SAP S/4HANA Cloud, an AI-first suite. This offering will help enterprises harness the power of AI and Gen AI in their SAP S/4HANA Cloud transformation journey.
State Bank of India (SBI)
The Board will meet on May 3 to consider raising equity during FY26 through follow-on public offer (FPO), rights issue, qualified institutional placement (QIP), or any other mode. The Board will also consider the March quarter and FY25 earnings on the same day.
GlaxoSmithKline Pharmaceuticals
Shareholders have approved the re-appointment of Juby Chandy as Whole-time Director & CFO of the company for a period of two years, effective April 1.
Nitin Kumar Yadav, IAS, Joint Secretary, Department of Commerce, has been appointed as Chairman & Managing Director (CMD) (additional charge) on the Board of the company for a period of one year, effective April 29.
The Board will consider the issue of bonus shares on May 2.
The company has received approval from the Real Estate Regulatory Authority (RERA) and has launched the residential project ‘The Prestige City – Indirapuram’ in the National Capital Region (NCR). The gross development value (GDV) of the project is estimated at over Rs 9,000 crore.
The company’s subsidiary, Strides Pharma Inc, in the US has acquired four approved ANDAs for the US market from Nostrum Laboratories Inc., USA. The portfolio comprises liquids and immediate-release solid orals in therapeutic segments that treat urinary tract infections (UTIs), pain management, allergy symptoms, attention deficit disorder (ADD/ADHD), and narcolepsy. The cumulative market size for the acquired portfolio is $57 million, as per IQVIA 2025 data.
The company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its Oncology (injectable and oral solid) formulation facility (F-2) at Panelav. The US FDA conducted the inspection on October 7–8, 2024.
Sumant Kathpalia has resigned as Managing Director & CEO, effective April 29. The Board has sought approval from the Reserve Bank of India (RBI) to constitute a Committee of Executives to discharge the duties, roles, and responsibilities of the CEO for an interim period until a permanent CEO is appointed. In his resignation letter, Kathpalia stated that he was stepping down in relation to the ongoing derivatives discussion and undertook moral responsibility for various acts of commission/omission.
Bulk Deals
TPG Rise Climate SF Pte sold a 3.91% stake in the company at an average price of Rs 673.26 per share, amounting to Rs 1,068.04 crore.
Block Deals
Blue Chandra Pte has exited the company by selling its entire 3.96% shareholding at an average price of Rs 174.3 per share, valued at Rs 152.01 crore. Buyers for the 3.96% stake at the same price included LGT Select Funds, BofA Securities Europe SA, CBJ as Trustee for SMBCTB Emerging Markets Impact MF, Citigroup, TT International, Steinberg India, and Tata Mutual Fund.
SME Listing on April 30
Tankup Engineers
Stocks Trade Ex-Dividend
Tanla Platforms
Vesuvius India
Stock Trades Ex-Date for Rights
Bannari Amman Spinning Mills
Stocks Trade Ex-Date for Resolution Plan -Suspension
Aanchal Ispat
KDJ Holidayscapes and Resorts
Stocks in F&O ban
RBL Bank
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
